Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.1 to Revision: v3.0.2. The 'Back to Top' element was removed, a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-14T00:18:28.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page has updated the publication date and version number of a study on tildrakizumab's efficacy and safety in psoriasis patients.
    Difference
    0.2%
    Check dated 2025-09-06T21:10:02.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Tildrakizumab and a new facility name and location, while removing several previous location details and drug information for Etanercept.
    Difference
    3%
    Check dated 2025-08-30T15:37:27.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-16T12:21:09.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.0%
    Check dated 2025-08-09T07:58:02.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.5%
    Check dated 2025-08-02T04:18:38.000Z thumbnail image

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.